Kimberly S. Waggie

1.4k total citations
31 papers, 984 citations indexed

About

Kimberly S. Waggie is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Kimberly S. Waggie has authored 31 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Kimberly S. Waggie's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Escherichia coli research studies (3 papers) and Bacteriophages and microbial interactions (3 papers). Kimberly S. Waggie is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Escherichia coli research studies (3 papers) and Bacteriophages and microbial interactions (3 papers). Kimberly S. Waggie collaborates with scholars based in United States, China and Slovakia. Kimberly S. Waggie's co-authors include Jeff L. Ellsworth, Emma Moore, Deborah Thompson, A.M. Bendele, Brendan Reardon, Michael W. Jakowec, Donald K. Ingram, Edward L. Spangler, John Hengemihle and Matthew S. Holdren and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Kimberly S. Waggie

29 papers receiving 958 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly S. Waggie United States 14 327 305 177 125 113 31 984
Fabrizio Fantini Italy 23 369 1.1× 138 0.5× 180 1.0× 123 1.0× 54 0.5× 59 1.5k
Michał Machnicki United States 14 501 1.5× 117 0.4× 175 1.0× 148 1.2× 77 0.7× 22 1.4k
Jules J.E. Doré United States 23 965 3.0× 118 0.4× 160 0.9× 106 0.8× 117 1.0× 41 1.9k
Akiko Mizokami Japan 21 676 2.1× 111 0.4× 238 1.3× 205 1.6× 86 0.8× 60 1.5k
Dominique Bernard France 22 689 2.1× 145 0.5× 341 1.9× 35 0.3× 125 1.1× 51 1.9k
Gerda Suchanek Austria 16 493 1.5× 82 0.3× 271 1.5× 39 0.3× 98 0.9× 20 1.5k
Mark T. Butt United States 22 248 0.8× 74 0.2× 297 1.7× 143 1.1× 131 1.2× 62 1.3k
Jessica Bright United States 12 566 1.7× 63 0.2× 184 1.0× 58 0.5× 213 1.9× 13 1.1k
Tadahiko Iijima Japan 17 523 1.6× 118 0.4× 148 0.8× 66 0.5× 40 0.4× 36 977
Michael H. Irwin United States 22 615 1.9× 124 0.4× 96 0.5× 66 0.5× 175 1.5× 36 1.3k

Countries citing papers authored by Kimberly S. Waggie

Since Specialization
Citations

This map shows the geographic impact of Kimberly S. Waggie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly S. Waggie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly S. Waggie more than expected).

Fields of papers citing papers by Kimberly S. Waggie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly S. Waggie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly S. Waggie. The network helps show where Kimberly S. Waggie may publish in the future.

Co-authorship network of co-authors of Kimberly S. Waggie

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly S. Waggie. A scholar is included among the top collaborators of Kimberly S. Waggie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly S. Waggie. Kimberly S. Waggie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bort, Susan, et al.. (2009). Anti-IL-21 monoclonal antibody reduces disease severity and inflammatory cytokines in a murine model of psoriasis and colitis (97.16). The Journal of Immunology. 182(Supplement_1). 97.16–97.16. 1 indexed citations
3.
Ellsworth, Jeff L., Nels Hamacher, Brandon Harder, et al.. (2009). Recombinant Soluble Human FcγR1A (CD64A) Reduces Inflammation in Murine Collagen-Induced Arthritis. The Journal of Immunology. 182(11). 7272–7279. 25 indexed citations
4.
Bilsborough, Janine, Ellen G. Chadwick, Sherri Mudri, et al.. (2008). TACI‐Ig prevents the development of airway hyperresponsiveness in a murine model of asthma. Clinical & Experimental Allergy. 38(12). 1959–1968. 13 indexed citations
5.
Cullen, John M., et al.. (2008). Harderian Gland Neoplasms in Captive, Wild-caught Beechey Ground Squirrels (Spermophilus beecheyi). Veterinary Pathology. 45(3). 388–392. 1 indexed citations
6.
Moore, Emma, A.M. Bendele, Deborah Thompson, et al.. (2005). Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis and Cartilage. 13(7). 623–631. 277 indexed citations
7.
Okada, Shannon, Jeff L. Ellsworth, Diane M. Durnam, et al.. (2005). A Glycoprotein Hormone Expressed in Corticotrophs Exhibits Unique Binding Properties on Thyroid-Stimulating Hormone Receptor. Molecular Endocrinology. 20(2). 414–425. 66 indexed citations
8.
Ponce, Rafael, Karen L. Andrews, Julie G. Hensler, et al.. (2005). Safety of Recombinant Human Factor XIII in a Cynomolgus Monkey Model of Extracorporeal Blood Circulation. Toxicologic Pathology. 33(6). 702–710. 7 indexed citations
9.
Hughes, S., et al.. (2004). Interleukin 21 efficacy in a mouse model of metastatic renal cell carcinoma. Journal of Clinical Oncology. 22(14_suppl). 2598–2598. 2 indexed citations
10.
Ellsworth, Jeff L., J. L. Berry, Thomas R. Bukowski, et al.. (2002). Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis and Cartilage. 10(4). 308–320. 165 indexed citations
11.
Waggie, Kimberly S., Ravi Tolwani, & David M. Lyons. (2000). Mammary Adenocarcinoma in a Male Squirrel Monkey (Saimiri sciureus). Veterinary Pathology. 37(5). 505–507. 10 indexed citations
12.
Green, Sherril L., Ravi Tolwani, Kimberly S. Waggie, & Glen Otto. (1999). ENDOMETRIOSIS AND A PARAOVARIAN CYST IN A RHESUS MACAQUE. Veterinary Radiology & Ultrasound. 40(3). 271–274. 3 indexed citations
13.
Waggie, Kimberly S., Philipp J. Kahle, & Ravi Tolwani. (1999). Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review.. PubMed. 49(4). 358–62. 13 indexed citations
14.
Waggie, Kimberly S. & Patricia L. Marion. (1997). Demodex sp. in California Ground Squirrels. Journal of Wildlife Diseases. 33(2). 368–370. 10 indexed citations
15.
Spangler, Edward L., Kimberly S. Waggie, William Rea, et al.. (1995). Relationship of hematological variables to learning performance in aged Fischer-344 rats. Neurobiology of Aging. 16(1). 85–89. 8 indexed citations
16.
Spangler, Edward L., et al.. (1994). Behavioral assessment of aging in male Fischer 344 and Brown Norway rat strains and their F1 hybrid. Neurobiology of Aging. 15(3). 319–328. 77 indexed citations
17.
Roth, G. S., et al.. (1993). Pathological Characterization of Male Wistar Rats From The Gerontology Research Center. Journal of Gerontology. 48(6). B213–B230. 13 indexed citations
18.
Riley, Lela K., Cynthia Besch‐Williford, & Kimberly S. Waggie. (1990). Protein and antigenic heterogeneity among isolates of Bacillus piliformis. Infection and Immunity. 58(4). 1010–1016. 13 indexed citations
19.
Spencer, Thomas H., James R. Ganaway, & Kimberly S. Waggie. (1990). Cultivation of Bacillus piliformis (Tyzzer) in mouse fibroblasts (3T3 cells). Veterinary Microbiology. 22(2-3). 291–297. 6 indexed citations
20.
Waggie, Kimberly S., et al.. (1981). A study of mouse strains susceptibility to Bacillus piliformis (Tyzzer's disease): the association of B-cell function and resistance.. PubMed. 31(2). 139–42. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabrizio Fantini Breakdown of academic impact, for papers by Michał Machnicki Breakdown of academic impact, for papers by Jules J.E. Doré Breakdown of academic impact, for papers by Akiko Mizokami Breakdown of academic impact, for papers by Dominique Bernard Breakdown of academic impact, for papers by Gerda Suchanek Breakdown of academic impact, for papers by Mark T. Butt Breakdown of academic impact, for papers by Jessica Bright Breakdown of academic impact, for papers by Tadahiko Iijima Breakdown of academic impact, for papers by Michael H. Irwin
Rankless by CCL
2026